Fenretinide: Induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells

Cell Growth and Differentiation

Volumn 8, Issue 1, 1997, Pages 101-111

  Roberson, Kathryn M ^a   Penland, Shannon N ^a   Padilla, George M ^a   Selvan, Rathinam S ^a   Kim, Choung Soo ^a   Fine, Robert L ^b   Robertson, Cary N ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Division of Medical Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; FEMALE; FENRETINIDE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031031450     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Lippman, S. M., Kessler, J. F., and Meyskens, F. L., Jr. Retinoids as preventive and therapeutic anti-cancer agents (Part 1). Cancer Treat. Rep., 71: 391-405, 1987.
2. Bollag, W. Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. The Lancet, 1: 860-863, 1983.
3. Sporn, M., and Roberts, A. Role of retinoids in differentiation and carcinogenesis. J. Natl. Cancer Inst., 73: 1381-1385, 1984.
4. Kelloff, G. J., Malone, W. F., Boone, C. W., Sigman, C. C., and Fay, J. R. Progress in applied chemoprevention research. Semin. Oncol., 17: 438-455, 1990.
5. Marth, C., Nock, G., and Daxenbichler, G. Effect of 4-hydroxyphenyl-retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst., 75: 871-875, 1985.
6. Robertson, C. N., Kidd, K. R., Pence, J. C., Trump, D. L., and Fine, R. L. N-(4-Hydroxyphenyl)retinamide-induced cytotoxicity of cultured human prostatic carcinoma cells. Surg. Forum. 43: 738-740, 1992.
7. Pollard, M., Luckert, P. H., and Sporn, M. B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51: 3610-3611, 1991.
8. Slawin, K., Kadmon, D., Park, S. H., Scardino, P. T., Anzano, M., Sporn, M. B., and Thompson, T. C. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc induced carcinomas in the mouse reconstruction model system. Cancer Res., 53: 4461-4465, 1993.
9. Pienta, K. J., Nguyen, N. M., and Lehr, J. E. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res., 53: 224-226, 1993.
10. Bunk, M. J., Kinehan, J. J., and Sarkar, N. H. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Cancer Lett., 26: 319-326, 1985.
11. Sani, B., Shealy, Y. F., and Hill, D. L. N-(4-Hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors. Carcinogenesis (Lond.), 16: 2531-2534, 1995.
12. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grigani, F., Grigani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U., and Pierotti, M. A. N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hematopoietic cell lines including those unresponsive to retinoic acid. Cancer Res., 53: 6036-6041, 1993.
13. Sheikh, M. S., Shao, Z. M., Li, X. S., Ordonez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Han, Q. X., Chao, W. R., Quick, T., Niles, R. M., and Fontana, J. A. N-(4-Hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor independent pathways in human breast carcinoma. Carcinogenesis (Lond.), 16: 2477-2486, 1995.
14. Di Vinci, A., Geido, E., Infusini, E., and Giaretti, W. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Int. J. Cancer, 59: 422-426, 1994.
15. Mariotti, A., Marcora, E., Bunone, G., Costa, A., Veronesi, U., Pierotti, M. A., and Valle, G. D. N-(4-Hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst., 86: 1245-1247, 1994.
16. Columbel, M., Olsson, C. A., Ng, P. Y., and Buttyan, R. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52: 4313-4319, 1992.
17. Martikainen, P., Kyprianou, N., Tucker, R. W., and Isaacs, J. T. Programmed death of nonproliferating androgen-independent prostatic cancer. Cancer Res., 51: 4693-4700, 1991.
18. Isaacs, J. T., Lundmo, P. I., Berges, R., Martikainen, P., Kyprianou, N., and English, H. F. Androgen regulation of programmed death of normal and malignant prostatic cells. J. Androl., 13: 457-464, 1992.
19. Kyprianou, N., and Isaacs, J. T. Expression of transforming growth factor β in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol., 3: 1515-1522, 1989.
20. Martikainen, P., Kyprianou, N., Isaacs, J. T. Effect of transforming growth factor β1 on proliferation and death of rat prostatic cells. Endocrinology, 127: 2963-2968, 1990.
21. Kyprianou, N., and Isaacs, J. T. Identification of a cellular receptor for transforming growth factor β in rat ventral prostate and its negative regulation by androgens. Endocrinology, 123: 2124-2131, 1988.
22. Shain, S. A., Lin, A. L., Koger, J. D., and Karaganis, A. G. Rat prostate cancer cells contain functional receptors for TGFβ. Endocrinology, 126: 818-825, 1990.
23. Rotello, R. J., Lieberman, R. C., Purchio, A. F., and Gerschenson, L. E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 3412-3415, 1991.
24. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., and Dickson, R. B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
25. Sporn, M. B., and Roberts, A. B. Interactions of retinoids and transforming growth factor β in regulation of cell differentiation and proliferation. Mol. Endocrinol., 5: 3-7, 1991.
26. Falk, L A., De Benedetti, F., Lohrey, N., Birchenall-Roberts, M. C., Ellingsworth, L. N., Faltynek, C. R., and Ruscetti, F. W. Induction of TGFβ1 protein production in retinoic acid treated HL-60 cells: possible TGFβ1 mediated autocrine inhibition. Blood, 77: 1248-1255, 1991.
27. Gucev, Z. S., Youngman, O., Kelley, K. M., and Rosenfeld, R. G. Insulin-like growth factor binding protein 3 mediates retinoic acid and TGFβ2 induced growth factor inhibition in human breast cancer cells. Cancer (Phila.), 56: 1545-1550, 1996.
28. Roberts, A. B., and Sporn, M. B. (eds.). Mechanistic interrelationships between two superfamilies: the steroid retinoid receptors and transforming growth factor β. In: Cancer Surveys: Growth Regulation by Nuclear Hormone Receptors, Vol. 14, pp. 205-220. Plainview, NY: Cold Spring Harbor Laboratory Press, 1992.
29. Ikeda, T., Lioubin, M. N., and Marquardt, H. Human transforming growth factor type (32: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry, 26: 2406-2410, 1987.
30. Igawa, M., Tanabe, T., Chodak, G. W., and Rukstalis, D. B. N-(4-Hydroxyphenyl)retinamide induces cell cycle specific growth inhibition in PC-3 cells. Prostate, 24: 299-305, 1994.
31. Kalemkerian, G. P., Slusher, R., Ramalingam, S., Gadgeel, S., and Mabry, M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst., 87: 1674-1680, 1995.
32. Oridate, N., Lotan, D., Xu, X. C., Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)-retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
33. Oridate, N., Lotan, D., Mitchell, M. F., Hong, W. K., and Lotan, R. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J. Cell. Biochem. Suppl., 23: 80-86, 1995,
34. Supino, R., Crosti, M., Clerici, M., Walters, A., Cleris, L., Zunino, F., and Formelli, F. Induction of apoptosis by fenretinide (4-HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int. J. Cancer, 65: 491-497, 1996.
35. Ponzoni, M., Bocca, P., Cheisa, V., Decensi, A., Pistoia, V., Raffaghello, L., Rozzo, C., and Montaldo, P. G. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res., 55: 853-861, 1995.
36. Reyes-Moreno, C., Frenette, G., Boulanger, J., Lavergne, E., Govindan, M. V., and Loutsilieris, M. Mediation of glucocorticoid receptor function by transforming growth factor β 1 expression in human PC-3 prostate cancer cells. Prostate, 26: 260-269, 1995.
37. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, J., Howley, P. M., and Moses, H. L TGFβ1 inhibition of c-myc in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell, 61: 777-785, 1990.
38. cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol. Cell. Biol., 11: 1185-1194, 1991.
39. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massagué, J. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell, 62: 175-185, 1990.
40. Danielpour, D. Induction of transforming growth factor-β autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J. Cell. Physiol., 166: 231-239, 1996.
41. Taipale, J., Matikainen, S., Hurme, M., and Keski-Oja, J. Induction of transforming growth factor β1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth & Differ., 5: 1309-1319, 1994.
42. Nunes, I., Kojima, S., and Rifkin, D. B. Effects of endogenously activated transforming growth factor-β on growth and differentiation of retinoic acid-treated HL-60 cells. Cancer Res., 56: 495-499, 1996.
43. Joiakim, A. P., and Chopra, D. P. Retinoic acid and calcium regulation of p53, transforming growth factor-β1, and transforming growth factor-α gene expression and growth in adenovirus 12-SV40-transformed human tracheal gland epithelial cells. Am. J. Respir. Cell Mol. Biol., 8: 408-416, 1993.
44. Miyazono, K., Thyberg, J., and Heldin, C. H. Retention of the TGFβ1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J. Biol. Chem., 267: 5668-5675, 1992.
45. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
46. Brown, P. D., Wakefield, L. M., Levinson, A. D., and Sporn, M. B. Physiochemical activation of recombinant latent transforming growth factor-βs 1, 2 and 3. Growth Factors, 3: 35-43, 1990.
47. Franzen, P., Ichijo, H., and Miyazono, K. Different signals mediate transforming growth factor β1 induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp. Cell Res., 207: 1-7, 1993.
48. Carruba, G., Pfeffer, U., Fecarotta, E., Coviello, D. A., D'Amato, E., Casto, M. L., Vidali, G., and Castagnetta, L. Estradiol inhibits growth of hormone-nonresponsive PC-3 human prostate cancer cells. Cancer Res., 54: 1190-1193, 1994.
49. Koli, K., and Keski-Oja, J. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor-β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res., 55: 1540-1546, 1995.
50. Moses, H. L., Yang, E. Y., and Pientenpol, J. A. TGFβ stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63: 245-247, 1990.
51. Delia, D., Aiello, A., Formelli, F., Fontanella, F., Costa, A., Miyashita, T., Reed, J. C., and Pierotti, M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood, 85: 359-367, 1995.
52. Hay, R., Macy, M., Chen, T. R., McClintock, P., and Reid, Y. ATCC Cell Lines and Hybridomas, Ed. 6, pp. 145-199. Rockville, MD: American Type Culture Collection, 1988.
53. Roberson, K. M., Padilla, G. M., Schmidt, J. M., Petrow, V., and Robertson, C. N. 6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-α-reductase activity. Prostate, 26: 28-34, 1995.
54. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay. Cancer Res., 48: 589-601, 1988.
55. Borner, M. M., Schneider, E., Pirnia, F., Sartor, O., Trepel, J. B., and Myers, C. E. The detergent Triton X-100 induces a death pattern in human carcinoma cell lines that resembles cytotoxic lymphocyte-induced apoptosis. FEBS Lett., 353: 129-132, 1994.
56. Gong, J., Traganos, F., and Darzynkiewicz, Z. A selective procedure for DMA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218: 314-319, 1994.
57. Robertson, C. N., Roberson, K. M., Padilla, G. M., O'Brien, E. T., Cook, J. M., Kim, C. S., and Fine, R. L. Diethylstilbestrol induces apoptosis in hormone-insensitive prostate cancer cells. J. Natl. Cancer Inst., 88: 908-917, 1996.
58. Hsu, S., Raine, M., and Franger, H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison study between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
59. Kerns, B. J., Pence, J. C., Huper, G., Kinney, R. B., and Iglehart, J. D. c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry. J. Histochem. Cytochem., 38: 1823-1830, 1990.
60. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform-extraction. Anal. Biochem., 162: 156-159, 1987.
61. Selvan, R. S., Butterfield, J. H., and Krangel, M. S. Expression of multiple chemokine genes by a human mast cell leukemia. J. Biol. Chem., 269: 13893-13898, 1994.
62. Kip1 in C3H 10T[ifrax,1,2] mouse fibroblasts. Cancer Res., 55: 1413-1416, 1995.